Abstract

In this paper, a novel simple method for VEGF immobilization was developed using a new genetically engineered vascular endothelial growth factor (VEGF) fused to IgG-Fc (abbreviated as VEGF-Fc). The fusion protein of VEGF-Fc was biosynthesized by eukaryocyte expression system with the cloning plasmid encoding VEGF165 and Fc domain. Owe to the hydrophobic-bind property of the Fc domain, the VEGF-Fc is efficiently immobilized on the surface of porous polycaprolactone (PCL) scaffold in our study. The quantitative assay of VEGF-Fc immobilization by ELISA showes that the VEGF-Fc can uniformly distributed throughout the PCL scaffold and the immobilization rate is above 96% that is much higher than that of commercial VEGF. Furthermore, the proliferation of HUVECs was improved two times in the VEGF-Fc immobilized PCL scaffold comparing with that in commercial VEGF in cell culture medium, which detected by the cellular glucose consumption assays.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call